सामग्री पर जाएँ

दवाओं की अंतःक्रिया

Capecitabine + Deferiprone

गंभीरता: गंभीर

Capecitabine and Deferiprone: major interaction.

अंतिम अपडेट

केवल स्वास्थ्य पेशेवरों के लिए — मात्र संदर्भ हेतु। यह पृष्ठ संक्षिप्त सारांश है, चिकित्सकीय सलाह नहीं है और आधिकारिक लेबल या नैदानिक निर्णय का विकल्प नहीं है। दवा लिखने या देने से पहले हमेशा जाँच करें।

इस पृष्ठ की नैदानिक सामग्री केवल अंग्रेज़ी में उपलब्ध है।

सारांश

Capecitabine, a fluorouracil prodrug, can cause myelosuppression, and deferiprone can cause agranulocytosis. Their combination increases the risk of severe neutropenia and infection.

इस इंटरैक्शन का सरल भाषा में अर्थ

Capecitabine and Deferiprone can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Capecitabine belongs to Oncology; Deferiprone belongs to Miscellaneous.

साक्ष्य स्तर: Moderate

ऐसा क्यों होता है

Additive myelosuppressive effects on neutrophils.

क्या करें

Avoid the combination when an alternative exists. Otherwise monitor absolute neutrophil count more often and hold deferiprone if neutropenia occurs.

फार्मासिस्ट से क्या पूछें

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ सदस्यों के लिए

पूरा पेज खोलें

Capecitabine और Deferiprone की पूरी प्रबंधन सलाह, अतिरिक्त नोट्स, साक्ष्य का विवरण और पूरे पर्चे का इंटरैक्शन चेकर खोलने के लिए खाता बनाएँ और Pro+ ट्रायल शुरू करें।

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

वेब पर Pro+ को 7 दिन मुफ़्त आज़माएँ। कार्ड की ज़रूरत नहीं।

अक्सर पूछे जाने वाले प्रश्न

Can I take Capecitabine with Deferiprone?

MediHelp rates the interaction as major. Capecitabine and Deferiprone can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Capecitabine, a fluorouracil prodrug, can cause myelosuppression, and deferiprone can cause agranulocytosis. Their combination increases the risk of severe neutropenia and infection.

How serious is the interaction between Capecitabine and Deferiprone?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid the combination when an alternative exists. Otherwise monitor absolute neutrophil count more often and hold deferiprone if neutropenia occurs.

What other medicines interact with Capecitabine?

MediHelp also lists interactions of Capecitabine with, for example, Adenovirus types 4 and 7 live, Arsenic trioxide, Axicabtagene ciloleucel. The full list is on the Capecitabine page.

MediHelp ऐप में पूर्ण मोनोग्राफ़, खुराक और इंटरैक्शन चेकर

MediHelp ऐप में पूरा संदर्भ खोलें, कई दवाओं की अंतःक्रियाएँ जाँचें और खुराक टूल इस्तेमाल करें।

A–Z ब्राउज़ करें · दवाओं की अंतःक्रिया

ऐप पाएँ साइन इन